New report sets out clear steps pharma cos to curb AMR risk in antibiotic production
The report also demonstrates how proactively adopting and scaling responsible manufacturing practices is a critical way for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Access to Medicine Foundation
We need companies to apply access approaches more systematically, consistently and at a larger scale…
Claudia Martinez, Lead for the Access to Medicine Index shares more insights from this year's report and recommends steps to…
Blueprint for progress
Experts and veterans examine and explore strategies for India Pharma Inc to implement the lessons learnt from the COVID-19…
Mental Health: A challenge and an opportunity
On Mental Health Day, Jayasree K Iyer, Executive Director, Access to Medicine Foundation highlights that mental health should be…
Why are children waiting so long for new meds?
COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics, and this may…
Open Science: Key to combat zoonosis
Largely opaque and proprietary R&D environments in the life sciences sector need to make way for strategies facilitated by…
Signs of progress against the superbugs, but not yet at the scale needed: Study
The 2020 Antimicrobial Resistance Benchmark evaluates how 30 pharmaceutical companies are limiting drug-resistance